Get the Stockscreener App
75.23
0.91%
0.625
Overview
News
Price History
Option Chain
Financials
Why CVS Down?
Discussions
Forecast
Stock Split
Dividend History
Cvs Health Corp stock is traded at $75.23, with a volume of 1.52M.
It is up +0.91% in the last 24 hours and up +5.23% over the past month.
CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates over 9,000 stores primarily in the US. CVS is also a large pharmacy benefit manager (acquired through Caremark), processing about 2 billion adjusted claims annually. It operates a top-tier health insurer (acquired through Aetna) through which it serves about 27 million medical members. The acquisition of Oak Street Health adds primary care services to the mix, which could have significant synergies with all existing business lines.
See More
Previous Close:
$74.61
Open:
$74.935
24h Volume:
1.52M
Relative Volume:
0.21
Market Cap:
$95.46B
Revenue:
$386.46B
Net Income/Loss:
$4.49B
P/E Ratio:
21.02
EPS:
3.58
Net Cash Flow:
$4.78B
1W Performance:
+0.49%
1M Performance:
+5.23%
6M Performance:
+12.04%
1Y Performance:
+27.59%
1-Day Range:
$74.53
$75.42
1-Week Range:
$73.80
$77.34
52-Week Range:
$43.56
$77.34
Cvs Health Corp Stock (CVS) Company Profile
Name
Cvs Health Corp
Sector
Industry
Phone
(401) 765-1500
Address
ONE CVS DR., WOONSOCKET
Compare CVS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CVS
Cvs Health Corp
|
75.26 | 94.63B | 386.46B | 4.49B | 4.78B | 3.58 |
|
UNH
Unitedhealth Group Inc
|
344.70 | 312.96B | 422.82B | 22.09B | 25.27B | 23.08 |
|
CI
Cigna Group
|
286.42 | 75.82B | 261.22B | 5.40B | 3.94B | 18.32 |
|
ELV
Elevance Health Inc
|
318.81 | 71.31B | 189.25B | 5.35B | 5.34B | 23.50 |
|
HUM
Humana Inc
|
253.38 | 30.60B | 123.11B | 1.58B | 2.44B | 13.03 |
Cvs Health Corp Stock (CVS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-18-25 | Upgrade | UBS | Neutral → Buy |
| Aug-14-25 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Feb-13-25 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Feb-12-25 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Jan-30-25 | Upgrade | Edward Jones | Hold → Buy |
| Dec-03-24 | Upgrade | Deutsche Bank | Hold → Buy |
| Nov-18-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Oct-10-24 | Upgrade | Barclays | Equal Weight → Overweight |
| Oct-04-24 | Upgrade | TD Cowen | Hold → Buy |
| May-30-24 | Initiated | Robert W. Baird | Neutral |
| May-07-24 | Downgrade | TD Cowen | Buy → Hold |
| May-02-24 | Downgrade | UBS | Buy → Neutral |
| May-01-24 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| May-01-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Mar-06-24 | Initiated | Barclays | Equal Weight |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Dec-22-23 | Initiated | HSBC Securities | Buy |
| Sep-19-23 | Upgrade | Evercore ISI | In-line → Outperform |
| Sep-12-23 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Aug-18-23 | Downgrade | Edward Jones | Buy → Hold |
| May-26-23 | Initiated | Piper Sandler | Overweight |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-03-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Nov-23-22 | Resumed | Morgan Stanley | Overweight |
| Jun-17-22 | Initiated | Loop Capital | Buy |
| May-27-22 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Mar-29-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Feb-11-22 | Downgrade | Raymond James | Strong Buy → Outperform |
| Dec-14-21 | Initiated | Goldman | Buy |
| Dec-01-21 | Initiated | Seaport Research Partners | Buy |
| May-19-21 | Initiated | Wells Fargo | Equal Weight |
| Mar-17-21 | Downgrade | Guggenheim | Buy → Neutral |
| Jan-08-21 | Upgrade | Jefferies | Hold → Buy |
| Sep-17-20 | Initiated | Piper Sandler | Overweight |
| Jul-01-20 | Initiated | SVB Leerink | Mkt Perform |
| May-14-20 | Upgrade | Credit Suisse | Neutral → Outperform |
| Sep-27-19 | Resumed | RBC Capital Mkts | Outperform |
| Sep-12-19 | Initiated | Deutsche Bank | Buy |
| Jun-05-19 | Upgrade | Standpoint Research | Hold → Buy |
| Apr-29-19 | Downgrade | Credit Suisse | Outperform → Neutral |
| Apr-18-19 | Initiated | Guggenheim | Buy |
| Apr-15-19 | Downgrade | Oppenheimer | Outperform → Perform |
| Apr-10-19 | Reiterated | BofA/Merrill | Buy |
| Mar-13-19 | Initiated | Bernstein | Outperform |
| Feb-20-19 | Downgrade | Wells Fargo | Outperform → Market Perform |
| Jan-17-19 | Initiated | UBS | Buy |
| Dec-18-18 | Initiated | Barclays | Overweight |
| Nov-29-18 | Resumed | Goldman | Neutral |
| Nov-28-18 | Initiated | Evercore ISI | Outperform |
| Oct-26-18 | Resumed | Wolfe Research | Peer Perform |
| Jul-09-18 | Upgrade | Citigroup | Neutral → Buy |
| Feb-27-18 | Resumed | BofA/Merrill | Buy |
| Feb-13-18 | Reiterated | Citigroup | Neutral |
View All
Cvs Health Corp Stock (CVS) Latest News
Popular healthcare retail chain files Chapter 11 bankruptcy - TheStreet
Leadership Powerhouse: ADP Taps Former CEOs of CVS Health and Intel to Join Board of Directors - Stock Titan
CVS Omnicare's Chapter 11 filing caps decade of struggles - The Business Journals
CVS Health Gains as Revenue Grows, Dividend Remains Strong - MarketBeat
CVS Health (CVS) Among PBMs Proposing Voluntary Changes to Avoid Regulation - GuruFocus
Why CVS Health (CVS) is a Top Momentum Stock for the Long-Term - Yahoo Finance
Investors Heavily Search CVS Health Corporation (CVS): Here is What You Need to Know - Yahoo Finance
Public Employees Retirement System of Ohio Decreases Position in CVS Health Corporation $CVS - MarketBeat
CVS Health (NYSE:CVS) Sets New 1-Year HighWhat's Next? - MarketBeat
CVS Health: A Deeply Undervalued Giant Investors Keep Ignoring - Seeking Alpha
CVS Moves To End Worker's Tobacco Surcharge ERISA Suit - Law360
Omnicare Can Tap $25M Initial DIP, Stage Set For Gov't Feud - Law360
Pharma middlemen propose regulatory changes to avoid Trump administration rules, Bloomberg News reports - Reuters
CVS Health (CVS) Stock Sees Minor Dip Amid Strong Yearly Performance - GuruFocus
Meet The Attys Helping CVS' Omnicare Through Ch. 11 - Law360
Aetna expanding clinical collaboration program with hospitals - Healthcare Finance News
TD Private Client Wealth LLC Raises Stake in CVS Health Corporation $CVS - MarketBeat
4,740 Shares in CVS Health Corporation $CVS Acquired by Northside Capital Management LLC - MarketBeat
Canoe Financial LP Has $111.21 Million Holdings in CVS Health Corporation $CVS - MarketBeat
CVS Health Corporation $CVS Shares Sold by Assenagon Asset Management S.A. - MarketBeat
IFM Investors Pty Ltd Acquires 10,457 Shares of CVS Health Corporation $CVS - MarketBeat
CX Institutional Grows Stake in CVS Health Corporation $CVS - MarketBeat
CVS Health Corporation $CVS Shares Acquired by Toth Financial Advisory Corp - MarketBeat
Waycross Partners LLC Takes Position in CVS Health Corporation $CVS - MarketBeat
CVS Health (NYSE:CVS) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Kingstone Capital Partners Texas LLC Acquires Shares of 2,145,239 CVS Health Corporation $CVS - MarketBeat
Park Avenue Securities LLC Boosts Stake in CVS Health Corporation $CVS - MarketBeat
Wedge Capital Management L L P NC Purchases New Shares in CVS Health Corporation $CVS - MarketBeat
CVS Health Corporation $CVS Shares Sold by Avanza Fonder AB - MarketBeat
International Private Wealth Advisors LLC Acquires New Holdings in CVS Health Corporation $CVS - MarketBeat
Why the Market Dipped But CVS Health (CVS) Gained Today - Yahoo Finance
CVS Health Ventures Leads $33.7M Series B For AmplifAI - citybiz
CVS Health subsidiary Omnicare files for Ch. 11 bankruptcy protection - Providence Business News
CVS Health Subsidiary Omnicare Files For Ch. 11 Bankruptcy Protection - Barchart.com
CVS Health’s Aetna expands clinical collaboration program to enhance support for hospitals - Drug Store News
CVS’s Omnicare Files for Bankruptcy After $949 Million Judgment - MSN
CVS’s Omnicare Files Bankruptcy After $949 Million Judgment - Yahoo Finance
CVS’s Omnicare Files Bankruptcy After $949 Million Judgment (1) - Bloomberg Law News
CVS Health Drives Drug Affordability by Promoting Competition - Yahoo Finance
CVS Health (NYSE:CVS) Hits New 1-Year HighHere's Why - MarketBeat
Mn Services Vermogensbeheer B.V. Sells 3,700 Shares of CVS Health Corporation $CVS - MarketBeat
CVS Health Corporation $CVS Position Increased by Swedbank AB - MarketBeat
CVS Health Corporation $CVS Stock Holdings Decreased by Alpha Omega Wealth Management LLC - MarketBeat
Procyon Advisors LLC Lowers Stake in CVS Health Corporation $CVS - MarketBeat
CVS Health Corporation $CVS Shares Sold by Community Trust & Investment Co. - MarketBeat
Cvs Health Corp Stock (CVS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.86%
0.37%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):